The decision to advance the second dose of the measles, mumps, rubella, and chickenpox vaccine from age six to one and a half was made after extensive staff work and in light of the measles outbreaks that have occurred in Israel and around the world over the past year. According to the Ministry of Health, advancing the vaccine is expected to reduce morbidity and mortality.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The decision to advance the second dose of the measles, mumps, rubella, and chickenpox vaccine from age six to one and a half was made after extensive staff work and in light of the measles outbreaks that have occurred in Israel and around the world over the past year. According to the Ministry of Health, advancing the vaccine is expected to reduce morbidity and mortality.